Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Sarcoma, Immunotherapy

Victor Villalobos

MD

🏢University of Colorado Cancer Center🌐USA

Associate Professor of Medicine

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Victor Villalobos at the University of Colorado is advancing immunotherapy for sarcoma, a historically immunotherapy-resistant cancer. His research has demonstrated pembrolizumab activity in alveolar soft part sarcoma and undifferentiated pleomorphic sarcoma — subtypes with high immune infiltration. His work to characterize the immune microenvironment across sarcoma subtypes is informing combination immunotherapy strategies.

Share:

🧪Research Fields 研究领域

sarcoma immunotherapy
alveolar soft part sarcoma
undifferentiated pleomorphic sarcoma
PD-1 blockade sarcoma
checkpoint inhibitor sarcoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Victor Villalobos 的研究动态

Follow Victor Villalobos's research updates

留下邮箱,当我们发布与 Victor Villalobos(University of Colorado Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment